68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients

Wolfgang Peter Fendler; Martin Barrio; Claudio Spick; Martin Allen-Auerbach; Valentina Ambrosini; Matthias Benz; Christina Bluemel; Ravinder Kaur Grewal; Constantin Lapa; Matthias Miederer; Guillaume Nicolas; Tibor Schuster; Johannes Czernin; Ken Herrmann

doi:10.2967/jnumed.116.179192

Research ArticleTheranostics

⁶⁸Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients

Wolfgang Peter Fendler, Martin Barrio, Claudio Spick, Martin Allen-Auerbach, Valentina Ambrosini, Matthias Benz, Christina Bluemel, Ravinder Kaur Grewal, Constantin Lapa, Matthias Miederer, Guillaume Nicolas, Tibor Schuster, Johannes Czernin and Ken Herrmann

Journal of Nuclear Medicine February 2017, 58 (2) 307-311; DOI: https://doi.org/10.2967/jnumed.116.179192

Wolfgang Peter Fendler

1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin Barrio

1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Claudio Spick

1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin Allen-Auerbach

1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Valentina Ambrosini

2Nuclear Medicine, Department of Experimental Diagnostic and Specialized Medicine, University of Bologna and S. Orsola-Malpighi Hospital, Bologna, Italy

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias Benz

3Clinic of Radiology and Nuclear Medicine, University of Basel Hospital, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christina Bluemel

4Department of Nuclear Medicine, Julius-Maximilians-University, Würzburg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ravinder Kaur Grewal

5Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Constantin Lapa

4Department of Nuclear Medicine, Julius-Maximilians-University, Würzburg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias Miederer

6Department of Nuclear Medicine, University Medical Center Mainz, Mainz, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Guillaume Nicolas

3Clinic of Radiology and Nuclear Medicine, University of Basel Hospital, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tibor Schuster

7Department of Family Medicine, McGill University, Montreal, Quebec, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johannes Czernin

1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ken Herrmann

1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data
Supplemental Patient Examples

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 58, Issue 2

February 1, 2017

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following 68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

⁶⁸Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients

Journal of Nuclear Medicine Feb 2017, 58 (2) 307-311; DOI: 10.2967/jnumed.116.179192

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

⁶⁸Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients

Journal of Nuclear Medicine Feb 2017, 58 (2) 307-311; DOI: 10.2967/jnumed.116.179192

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT
111In-Pentetreotide Scintigraphy Versus 68Ga-DOTATATE PET: Impact on Krenning Scores and Effect of Tumor Burden
Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented
Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies
68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study
Somatostatin Receptor 2-Targeting Compounds

Google Scholar

Theranostics

¹⁷⁷Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer
Terbium-161, a Promising New Theranostic Radionuclide
Association of change in PSMA avid tumor burden during 177Lu-PSMA-617 therapy with overall survival: Should mid-point PET become standard protocol?

Show more Theranostics

Clinical

Addition of ¹³¹I-MIBG to PRRT (⁹⁰Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
SUVs Are Adequate Measures of Lesional ¹⁸F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?

Show more Clinical

Keywords

neuroendocrine tumor
agreement
reproducibility
PET/CT
DOTATATE
interobserver

Main menu

User menu

Search

⁶⁸Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Theranostics

Clinical

Similar Articles

Keywords